J Bronchology Interv Pulmonol. 2025 Aug 4;32(4):e01022. doi: 10.1097/LBR.0000000000001022. eCollection 2025 Oct 1.
ABSTRACT
BACKGROUND: This study aimed to evaluate the trends in the use of endobronchial valve (EBV) and video-assisted thoracoscopic surgery (VATS) for bronchopulmonary fistula (BPF) between 2016 and 2021, and to compare their clinical and economic outcomes.
METHODS: We conducted a retrospective analysis of national inpatient data from 2016 to 2021 to identify patients (age ≥18 y) with BPF who underwent EBV or VATS. Patients who had both EBV and VATS were excluded. We examined the annual procedure volumes, mean costs, length of stay (LOS), and in-hospital mortality rates. Statistical analyses were performed to compare outcomes between the 2 interventions.
RESULTS: Out of 13,245 patients with BPF, 660 underwent EBV and 535 underwent VATS. The total number of yearly EBV increased from 65 to 230 (P=0.043) and the total number of yearly VATS increased from 65 to 180 (P=0.854). Mortality rate (P=0.843), total cost (P=0.735), and LOS (P=0.337) remained stable for EBV patients. We observed a reduced mortality trend for VATS patients (P=0.041), while total cost (P=0.839), and LOS (P=0.886) remained stable.
CONCLUSION: EBV has become significantly more prevalent in BPF management. This could be due to increasing expertise and demand for a procedure for patients too critical to undergo VATS. VATS was associated with a mortality reduction between 2016 and 2021, which could be attributed to more strict patient selection.
PMID:40758241 | DOI:10.1097/LBR.0000000000001022
